More about

Peripheral Artery Disease

News
April 20, 2022
1 min read
Save

Steerable microcatheter nets FDA 510(k) clearance for neurologic, peripheral, coronary use

Steerable microcatheter nets FDA 510(k) clearance for neurologic, peripheral, coronary use

Bendit Technologies announced it received FDA 510(k) clearance for its steerable microcatheter platform for treatment in the neurologic, peripheral and coronary vasculature.

News
April 19, 2022
2 min read
Save

SCAI publishes recommendations for transaxillary arterial access

SCAI publishes recommendations for transaxillary arterial access

The Society for Cardiovascular Angiography and Interventions published its recommendations for percutaneous placement of large-bore arterial sheaths and devices specifically via transaxillary arterial access.

News
April 12, 2022
1 min read
Save

FDA clears support catheter platform for coronary use

FDA clears support catheter platform for coronary use

Transit Scientific announced the FDA cleared its support catheter platform for coronary use.

News
March 28, 2022
3 min read
Save

PAD drives worse limb outcomes, mortality in acute MI with cardiogenic shock

PAD drives worse limb outcomes, mortality in acute MI with cardiogenic shock

Comorbid peripheral artery disease is a significant risk factor for adverse events for patients with acute MI with cardiogenic shock, including worse limb outcomes and poorer short- and long-term survival compared with those without PAD.

News
March 10, 2022
1 min read
Save

Self-expanding stent for transradial peripheral procedures gains FDA approval

Self-expanding stent for transradial peripheral procedures gains FDA approval

Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral procedures in the iliac and superficial femoral arteries.

News
February 25, 2022
1 min read
Save

Arrow recalls percutaneous thrombolytic device due to risk for tip damage during use

Arrow recalls percutaneous thrombolytic device due to risk for tip damage during use

Arrow International issued a recall of its percutaneous thrombolytic device due to risk for tip damage during use and subsequent detachment from the basket.

News
February 08, 2022
2 min read
Save

DCB effective for PAD treatment at 5 years regardless of sex, diabetes status

DCB effective for PAD treatment at 5 years regardless of sex, diabetes status

In a real-world registry of patients with peripheral artery disease, 5-year outcomes of a drug-coated balloon were positive regardless of sex and diabetes status, researchers reported at the International Symposium on Endovascular Therapy.

News
February 07, 2022
2 min read
Save

Paclitaxel-coated balloon does not confer elevated mortality risk at 5 years

Paclitaxel-coated balloon does not confer elevated mortality risk at 5 years

In a patient-level meta-analysis of two pivotal trials of a paclitaxel-coated balloon, the paclitaxel-coated balloon was not associated with elevated risk for mortality in patients with peripheral artery disease at 5 years.

News
February 03, 2022
2 min read
Save

Speaker: Time to ‘move on’ from mortality-related concerns of paclitaxel-coated devices

Speaker: Time to ‘move on’ from mortality-related concerns of paclitaxel-coated devices

Contemporary data suggest paclitaxel-coated devices do not elevate mortality risk in patients with peripheral artery disease, and they should be used more routinely, according to a speaker.

News
January 21, 2022
1 min read
Save

Medtronic recalls directional atherectomy system due to risk for tip damage during use

Medtronic recalls directional atherectomy system due to risk for tip damage during use

Medtronic is recalling its HawkOne Directional Atherectomy System due to risk for the tip of the catheter becoming damaged during use, which may include the catheter tip breaking off or separating, according to an FDA press release.

View more